Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: Evaluation of TTP399 in Patients With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on TTP399 in patients with Type 1 diabetes across Phase 1 and Phase 2 completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TTP399 (glucokinase activator)

Snippet

Sponsor: vTv Therapeutics | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-03